When searching for companies, that could have a wide economic moat, I often screen for different metrics. These are metrics like high – and consistent – growth rates, stable margins, outperformance of a stock and high RoIC as well as RoE. And one
Edwards Lifesciences: Priced For Perfection
Summary
- Edwards Lifesciences is a global leader of patient-focused medical innovations for structural heart disease as well as critical care monitoring.
- The company not only can expect high growth rates in the years to come, it also has a wide economic moat around its business.
- But, right now, the stock is priced for perfection.
My analysis is focused on high-quality companies, that can outperform the market over the long-run due to a competitive advantage (economic moat) and high levels of defensibility. Focused on European and North American companies, but without constraints regarding market capitalization (from large cap to small cap companies).My academic background is in sociology and I hold a Master’s Degree in Sociology (with main emphasis on organizational and economic sociology) and a Bachelor’s Degree in Sociology and History.
Analyst’s Disclosure:I am/we are long MMM. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.